Add BrightSurf on Google Email

Cryo-electron microscopy captures structure of a protein pump

Researchers at Tohoku University used cryo-electron microscopy to determine the high-resolution 3D structure of human SPCA1a, a protein pump involved in calcium and manganese ion transport. The study provided insights into how the protein works and how mutations can cause Hailey-Hailey disease and other neurodegenerative disorders.

SourceTohoku University·JournalScience Advances·DateMar 24, 2023

How to generate new neurons in the brain

Researchers at UNIGE and UNIL have discovered the importance of cell metabolism in reactivating quiescent neural stem cells, increasing new neurons in adult mice. This breakthrough could lead to potential treatments for conditions like depression and neurodegenerative diseases.

SourceUniversité de Genève·JournalScience Advances·TypeNews article·DateMar 1, 2023

RNA modification ‘pivotal’ for protein linked to neurodegeneration in ALS

A study found that RNA methylation plays a pivotal role in TDP-43-related neurodegeneration in ALS. The researchers observed highly abundant RNA methylation in the end-stage tissues of patients with ALS. This discovery opens up new avenues for research into the disease, which is linked to environmental exposure.

SourceMichigan Medicine - University of Michigan·JournalMolecular Cell·TypeExperimental study·DateFeb 27, 2023

Reimagining drugs for rare brain disorder

A team of researchers has developed a new method to screen FDA-approved drugs to determine if they could be repurposed or improved to help patients with spinocerebellar ataxia type 5 (SCA5), a rare and debilitating disease. The pipeline uses cutting-edge spectroscopy to examine the interaction between mutant β-III-spectrin and actin, i...

SourceAmerican Society for Biochemistry and Molecular Biology·JournalJournal of Biological Chemistry·TypeExperimental study·DateFeb 16, 2023

The secrets of polydopamine coatings revealed

Researchers at the University of Groningen have discovered the exact structure of polydopamine coatings, which could lead to new applications in surface adhesion and neurodegenerative disease treatment. The study found that these coatings form through auto-oxidation, crosslinking and isomerization processes.

SourceUniversity of Groningen·JournalNature Communications·TypeExperimental study·DateFeb 16, 2023

How protein-rich droplets form

Scientists have developed a new method to measure calorimetric quantities at the molecular level with picosecond time resolution. By tracking water's spectroscopic fingerprints in the THz range, researchers can accurately predict protein-rich droplet formation and its dependency on external parameters like temperature.

SourceRuhr-University Bochum·JournalThe Journal of Physical Chemistry Letters·TypeExperimental study·DateFeb 10, 2023

Reading out RNA structures in real time

Scientists have developed a technique to detect RNA structures in live cells, shedding light on the role of G-quadruplexes in neurodegenerative diseases. The method uses fluorescent spectroscopy and resolves existing limitations in studying these structures in real-time.

SourceHokkaido University·JournalNucleic Acids Research·TypeExperimental study·DateFeb 1, 2023

Aging | Transcriptomic analysis of human ALS skeletal muscle reveals a disease-specific pattern of dysregulated circRNAs

A new study has identified distinct patterns of circular RNA expression in human ALS muscle tissue, which display disease-specific gradients and could inform about neuromuscular molecular programs in ALS. The research reveals that specific circRNAs are elevated in ALS muscle biopsies but reduced in spinal cord samples from ALS patients.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateJan 12, 2023

Study traces shared and unique cellular hallmarks found in 6 neurodegenerative diseases

A recent study has identified common and unique cellular processes in six neurodegenerative diseases, providing new insights into the underlying causes of these conditions. The research used machine learning analysis to compare RNA markers in whole blood samples from patients with distinct diseases, revealing eight shared themes across...

SourceArizona State University·JournalAlzheimer s & Dementia·TypeData/statistical analysis·DateDec 21, 2022

Dementia was associated with COVID-19 mortality, but the association was weaker than in previously published studies

A retrospective cohort study of 28,311 COVID-19 patients in Germany found a significant association between dementia and increased risk of death. The association was weaker than previously reported studies, suggesting potential changes in the impact of dementia on COVID-19 mortality over time.

SourceIOS Press·JournalJournal of Alzheimer’s Disease·TypeMeta-analysis·DateDec 20, 2022

New findings on memory impairment in epilepsy

Researchers at the University of Bonn discovered that people with chronic epilepsy may have impaired dendritic integration, leading to less specific place cell firing and reduced ability to distinguish familiar from unfamiliar places. Administering a sodium ion channel inhibitor improved memory in animal models.

SourceUniversity of Bonn·JournalBrain·DateDec 19, 2022

New treatments for Huntington’s disease

An interdisciplinary team from Erlangen has found a new treatment for Huntington's disease by accelerating the degradation of a specific messenger molecule necessary for protein synthesis. This reduces the huntingtin level in patients, offering new hope for long-term implementation of RNA-modifying approaches for fatal diseases.

SourceFriedrich-Alexander-Universität Erlangen-Nürnberg·JournalNature Communications·TypeExperimental study·DateDec 8, 2022

New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows

A new laboratory test can measure levels of amyloid beta oligomers in blood samples, detecting toxic proteins up to years before cognitive impairment. The test, SOBA, has shown promising results in identifying individuals at risk or incubating Alzheimer's disease.

SourceUniversity of Washington·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateDec 5, 2022

Imaging biomarkers for Alzheimer’s disease

Scientists have developed an AI method to pinpoint cells indicative of Alzheimer's disease based on DNA packing in mouse brain images, offering a potential early detection tool. This approach combines multi-scale imaging with artificial intelligence to identify biomarkers for aging-related diseases.

SourcePaul Scherrer Institute·JournalNature Communications·TypeImaging analysis·DateDec 3, 2022

Controversial Alzheimer's drug approval sparks surprising impact

A survey by UCI MIND found that media coverage of the FDA's decision made people less willing to volunteer for Alzheimer's pharmaceutical trials. The study highlights the powerful influence of media coverage on scientific research and emphasizes the need for diverse populations in clinical trials.

SourceIOS Press·JournalJournal of Alzheimer’s Disease·TypeMeta-analysis·DateNov 30, 2022

Cleveland Clinic study identifies blood pressure drug as potential treatment for Black patients with Alzheimer’s disease

A new study published in Alzheimer's & Dementia found that telmisartan, a blood pressure medication, is associated with lower risk of Alzheimer's specifically in Black patients over 60. The study analyzed data from over 5 million patients and suggests that future clinical trials should prioritize minority populations to find or reinfor...

SourceCleveland Clinic·JournalAlzheimer s & Dementia·DateNov 4, 2022

UCLA researchers offer roadmap for identifying new neuroprotective treatments by leveraging sex differences

Researchers from UCLA have developed a strategy to identify novel treatments for cognitive decline and neurodegenerative diseases by exploiting sex differences in the brain. The study provides a roadmap for disentangling the contribution of sex-specific factors, which can yield treatments optimized for each sex.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Experimental Medicine·DateNov 4, 2022

Alzheimer's or Lewy body dementia? How patients draw can determine the type of dementia

A study published in the Journal of Alzheimer's Disease found that analyzing patients' drawing tests can help diagnose Alzheimer's disease (AD) and distinguish it from dementia with Lewy bodies (DLB). The researchers discovered that DLB patients showed differences in speed-, pressure-, and pause-related features, whereas AD patients sh...

SourceUniversity of Tsukuba·JournalJournal of Alzheimer’s Disease·DateNov 3, 2022

Speaking your mind: patients' speech can reveal type of dementia

A study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring found that analyzing patients' speech can distinguish between different types of dementia. The research team developed a machine learning model using speech features to identify Alzheimer's disease and Lewy body dementia.

SourceUniversity of Tsukuba·JournalAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·DateNov 3, 2022